Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemia

In this study, we first initiated a multicenter, single-arm, phase-II clinical trial using decitabine (DAC) (20mg/m(2) for five days) based chemotherapy, followed by haploidentical lymphocyte infusion (HLI) that was applied as induction therapy for elderly patients with AML. Furthermore, the role of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Jing, Yu, Jin, Xiangshu, Wang, Lixin, Dou, Liping, Wang, Quanshun, Yao, Yushi, Lian, Shimei, Zhou, Jihao, Zhu, Haiyan, Yao, Zilong, Gao, Lijun, Wang, Lili, Li, Yonghui, Bai, Xuefeng, Fang, Meiyun, Yu, Li
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581138/
https://ncbi.nlm.nih.gov/pubmed/28881839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11183
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados